(Source: Allergan plc) DUBLIN and BUDAPEST, Hungary, May 12, 2016 /PRNewswire/ -- Allergan plc (NYSE: AGN) and Gedeon Richter Plc. today announced that nine posters highlighting additional scientific data and clinical research on cariprazine, an atypical antipsychotic, will be presented during the upcoming American Psychiatric Association Annual Meeting in Atlanta, GA, May 14 to May 18, 2016. Logo - http://photos.prnewswire.com/prnh/20150612/222796LOGO 'Advancing scientific discovery and addressing unmet clinical needs are at the heart of Allergan's Open Science approach,' said Dr. David Nicholson, President & Executive Vice President, Global R&D at Allergan. 'The abstracts presented at APA...
↧